Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Augmenting Exposure Therapy for Social Anxiety With Transcranial Direct Current Stimulation

NCT: NCT03743571 · TERMINATED

NCT IDNCT03743571
StatusTERMINATED
Start Date2019-04-02
Completion2020-03-05

Brief Summary

This study will examine whether transcranial direct current stimulation (tDCS) can be used to improve outcomes from exposure therapy for social anxiety disorder, and facilitate extinction of fear responding toward individuals outside one's own ethnic group (i.e., ethnic out-group members).

Frequently Asked Questions

What is Augmenting Exposure Therapy for Social Anxiety With Transcranial Direct Current Stimulation?

Augmenting Exposure Therapy for Social Anxiety With Transcranial Direct Current Stimulation is a clinical trial registered under NCT03743571. Current status: TERMINATED.

What is the status of NCT03743571?

The current status of NCT03743571 (Augmenting Exposure Therapy for Social Anxiety With Transcranial Direct Current Stimulation) is: TERMINATED.

When did Augmenting Exposure Therapy for Social Anxiety With Transcranial Direct Current Stimulation start?

Augmenting Exposure Therapy for Social Anxiety With Transcranial Direct Current Stimulation started on 2019-04-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑